SEC Form 4 · accession 0001140361-16-072594
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen A Dawes
Director
Period of report
Jul 14, 2016
Accepted (ET)
Jul 15, 2016 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 14, 2016 | A | 20,000 | $0.00 | A | 75,764 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Ms. Dawes was awarded 20,000 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units will vest in equal annual installments over a five (5) year period, on the earlier of, (i) May 11th of such year and (ii) Repligen Corporation's annual meeting of its stockholders held in such year. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.